InvestorsHub Logo
Followers 24
Posts 5025
Boards Moderated 1
Alias Born 11/16/2007

Re: None

Thursday, 04/07/2011 8:49:34 AM

Thursday, April 07, 2011 8:49:34 AM

Post# of 2118
http://seekingalpha.com/article/260886-future-biotech-superstars?source=yahoo


Biodel (BIOD): Involved in diabetes and sporting a tiny market cap of $55.77 million, BIOD shows strength in its cash on hand ($22.79 million, or $0.84/share), strong insider holdings (31.59 percent), and strong up volume so far in 2011. With a short interest of 19.2 percent, this stock could be a good short squeeze opportunity if it continues to pick up momentum.